Advancing evidence-generating medicine
Osmind’s research is helping to set new standards for mental health interventions and improve patient outcomes. See how we work with research partners to generate real-world evidence to accelerate advances in mental health care.
Selected research projects
Ketamine Infusion Therapy for PTSD: Real World Outcomes in over 8,000 patients
McInnes, L. A., Berman, R. M., & Shih, E. (2026). Ketamine infusion therapy for PTSD: Real-world outcomes in over 8,000 patients. Symposium presentation at the ASKP Annual Meeting, January 2026.
Osmind provides regulatory-grade RWE in support of New Drug Application
Differential Associations of Body Mass Index with Depression, Anxiety, and PTSD Symptom Trajectories in Patients Receiving Ketamine Infusion Therapy in the Real World
Sauvé, W., McIntyre, R., Qian, J., McInnes, L.A., Berman, R.M., Shih, E. (2025). Differential Associations of Body Mass Index with Depression, Anxiety, and PTSD Symptom Trajectories in Patients Receiving Ketamine Infusion Therapy in the Real World. Poster presented at ACNP Annual Meeting, Paradise Island, Bahamas.
Psychedelics care delivery infrastructure
Huang, L., Qian, J., Sauvé, W., Cantor Fitzgerald webinar series
Integrating Psychedelics Into the US Healthcare System: Insights From Interventional Psychiatry Practices and Legal Psilocybin Services in Oregon
Qian, J., CNS Summit, Boston, MA
Real-world Outcomes of Facilitated Psilocybin Sessions under Oregon's Legal Framework
Davis, J., Gow, A., Reid, R., Shih, E., Qian, J.J., McInnes, L.A., Sauve, W.M., Carhart-Harris, R. (2025). Real-world Outcomes of Facilitated Psilocybin Sessions under Oregon's Legal Framework. Poster presented at Psych Congress 2025, San Diego, CA.
Let's transform mental health together
Click here to learn more about our research or to discuss collaboration opportunities.
